Pharmaceutical giant Gilead Sciences has agreed to donate drugs that reduce the risk of HIV transmission for up to 200,000 people a year, the Trump administration says.
The agreement between Gilead and the Trump administration will last until at least Dec. 31, 2025, and possibly through the end of 2030, Health and Human Services Secretary Alex Azar said in a statement Thursday. Gilead will donate its PrEP medication Truvada, which is used to reduce the risk of HIV infection and usually sells for $1,600 to $2,000 a month in the United States.
The deal will “help us achieve our goal of ending the HIV epidemic in America!,” President Donald Trump said in a tweet.
About the Author
Think what you want Mr. Little
Susan M. Bauer 🎯🙌💯👏‼️✅️🫶💜🫂 Silence achieves very little in the grand scheme of things. I'll take the heat for speaking…
You are correct on several things here. 1. I DO have a high opinion of myself and I've worked very…
No, you take yourself way too seriously. Go get yourself some crayons, coloring books, some play-dough and find yourself a…
lol yall Crack me up that are too afraid to use your real names. Have you nothing better to do?…